Alcoholic Hepatitis (AH) Enrolling by Invitation Phase 2 Trials for Rifaximin (DB01220)

Also known as: Alcoholic Hepatitis / Hepatitis alcoholic / Hepatitis, Alcoholic

IndicationStatusPhase
DBCOND0080941 (Alcoholic Hepatitis (AH))Enrolling by Invitation2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02116556Effects of Rifaximin in Patients With Acute Alcoholic HepatitisTreatment